On Wednesday, 5-year-old Mary Stegmueller will reach a major milestone. She will have outlived her predicted life expectancy. Twice.
Apr 11, 2022
0
57
Patients with non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitor sotorasib (Lumakras) had a two-year overall survival rate of 32.5 percent, according to data from the CodeBreaK 100 clinical trial presented ...
Apr 10, 2022
0
8
New research has found that the weakened immune systems of blood cancer patients can improve after they receive a third COVID-19 vaccination.
Mar 25, 2022
0
98
Queensland research is providing new hope to immunocompromised people who are vulnerable to COVID-19. Scientists from QIMR Berghofer have discovered promising evidence that T cell immunotherapy could help them to fight against ...
Mar 22, 2022
0
20
Patients who are at a higher risk of their lung cancer returning can be identified by a personalized blood test that is performed after treatment, according to researchers at the University of Cambridge.
Mar 18, 2022
0
72
A team led by researchers at Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Harvard Medical School has developed a new method to identify thousands of DNA mutations accurately and efficiently in a patient's ...
Mar 18, 2022
0
106
March is National Kidney Month, which makes this a good time to learn about kidney cancer.
Mar 15, 2022
0
18
New research has begun to unravel the mystery of why a particular form of leukemia in infants has defied efforts to improve outcomes, despite significant improvements in treating older children. Scientists from the Wellcome ...
Mar 14, 2022
0
92
New research from the University of East Anglia (UEA) and Quadram Institute reveals how our immune system can be triggered to attack cancer cells.
Mar 1, 2022
0
80
Melanoma, a type of skin cancer, is often curable when detected and treated in its early stages. However, the disease can rapidly spread to other organs in the body and become deadly. According to the American Cancer Society, ...
Feb 17, 2022
0
20
